Study types
- article 2
Frequent coauthors
- Zefeng Xu 2
- Lijuan Pan 2
- Peihong Zhang 2
- Shiqiang Qu 2
- Tiejun Qin 2
- Yudi Zhang 2
- Zhijian Xiao 2
- Bing Li 2
- Xin Yan 1
- Gang Huang 1
article
2022
Ruxolitinib is a safe and effective therapy of myeloproliferative neoplasm-associated (MPN) myelofibrosis. However, often there are dose reductions and/or therapy interruptions because of therapy-related adverse events (AEs), especially ane…
article
2018
Abstract Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence. Danazol is also effective in some persons with PMF a…